Vanderbilt University School of Medicine

Lewis, Julia B. , M.D.
Professor of Medicine

Lab Url: N/A

Phone Number:

Email Address:julia.lewis@vanderbilt.edu

Lewis, Julia's picture

Office Address   Mailing Address

S-3223 MCN 2372


Publications
Lewis, EJ, Greene, T, Spitalewiz, S, Blumenthal, S, Berl, T, Hunsicker, LG, Pohl, MA, Rohde, RD, Raz, I, Yerushalmy, Y, Yagil, Y, Herskovits, T, Atkins, RC, Reutens, AT, Packham, DK, Lewis, JB, , . Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol, 23(1), 131-6, 2012. PMCID:3269925

Packham, DK, Alves, TP, Dwyer, JP, Atkins, R, de Zeeuw, D, Cooper, M, Shahinfar, S, Lewis, JB, Lambers Heerspink, HJ. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Am J Kidney Dis, 59(1), 75-83, 2012.

, . Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J Hypertens, 29(4), 623-35, 2011.

Basford, AW, Lewis, J, Dwyer, JP, Fogo, AB. Membranous nephropathy with crescents. J Am Soc Nephrol, 22(10), 1804-8, 2011.

Booth, BD, Vilt, SG, Lewis, JB, Rivera, JL, Buehler, EA, McCabe, C, Jennings, GK. Tribological durability of silane monolayers on silicon. Langmuir, 27(10), 5909-17, 2011.

Brackett, MG, Lewis, JB, Messer, RL, Lei, L, Lockwood, PE, Wataha, JC. Dysregulation of monocytic cytokine secretion by endodontic sealers. J Biomed Mater Res B Appl Biomater, 97(1), 49-57, 2011.

Dwyer, JP, Lewis, JB. Olmesartan to prevent the development of microalbuminuria: is it new? Is it true? Is it important. Am J Kidney Dis, 58(5), 700-3, 2011.

Holtkamp, FA, de Zeeuw, D, de Graeff, PA, Laverman, GD, Berl, T, Remuzzi, G, Packham, D, Lewis, JB, Parving, HH, Lambers Heerspink, HJ. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J, 32(12), 1493-9, 2011.

Kershaw, TS, Arnold, A, Lewis, JB, Magriples, U, Ickovics, JR. The Skinny on Sexual Risk: The Effects of BMI on STI Incidence and Risk. AIDS Behav, 15(7), 1527-38, 2011.

Lewis, EJ, Lewis, JB, Greene, T, Hunsicker, LG, Berl, T, Pohl, MA, de Zeeuw, D, Heerspink, HL, Rohde, RD, Atkins, RC, Reutens, AT, Packham, DK, Raz, I, , . Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis, 58(5), 729-36, 2011.

McCoy, AB, Waitman, LR, Lewis, JB, Wright, JA, Choma, DP, Miller, RA, Peterson, JF. A framework for evaluating the appropriateness of clinical decision support alerts and responses. J Am Med Inform Assoc, , , 2011.

Morgado, P, Laginhas, CM, Lewis, JB, McCabe, C, Martins, LF, Filipe, EJ. Viscosity of liquid perfluoroalkanes and perfluoroalkylalkane surfactants. J Phys Chem B, 115(29), 9130-9, 2011.

Morgado, P, Lewis, JB, Laginhas, C, Martins, LF, McCabe, C, Blas, FJ, Filipe, EJ. Systems Involving Hydrogenated and Fluorinated Chains: Volumetric Properties of Perfluoroalkanes and Perfluoroalkylalkane Surfactants. J Phys Chem B, , , 2011.

Persson, F, Lewis, JB, Lewis, EJ, Rossing, P, Hollenberg, NK, Parving, HH. Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy. J Renin Angiotensin Aldosterone Syst, , , 2011.

Persson, F, Lewis, JB, Lewis, EJ, Rossing, P, Hollenberg, NK, Parving, HH. Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy. Clin J Am Soc Nephrol, 6(5), 1025-31, 2011.

Weir, AB, Lewis, JB, Arteta-Bulos, R. Chronic idiopathic neutrophilia: experience and recommendations. South Med J, 104(7), 499-504, 2011.

Appel, LJ, Wright, JT, Greene, T, Agodoa, LY, Astor, BC, Bakris, GL, Cleveland, WH, Charleston, J, Contreras, G, Faulkner, ML, Gabbai, FB, Gassman, JJ, Hebert, LA, Jamerson, KA, Kopple, JD, Kusek, JW, Lash, JP, Lea, JP, Lewis, JB, Lipkowitz, MS, Massry, SG, Miller, ER, Norris, K, Phillips, RA, Pogue, VA, Randall, OS, Rostand, SG, Smogorzewski, MJ, Toto, RD, Wang, X, , . Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med, 363(10), 918-29, 2010.

Brackett, MG, Messer, RL, Lockwood, PE, Bryan, TE, Lewis, JB, Bouillaguet, S, Wataha, JC. Cytotoxic response of three cell lines exposed in vitro to dental endodontic sealers. J Biomed Mater Res B Appl Biomater, 95(2), 380-6, 2010.

Go, AS, Parikh, CR, Ikizler, TA, Coca, S, Siew, ED, Chinchilli, VM, Hsu, CY, Garg, AX, Zappitelli, M, Liu, KD, Reeves, WB, Ghahramani, N, Devarajan, P, Faulkner, GB, Tan, TC, Kimmel, PL, Eggers, P, Stokes, JB, , . The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol, 11, 22, 2010. PMCID:2944247

Hung, AM, Crawford, DC, Griffin, MR, Brown-Gentry, K, Lipkowitz, MS, Siew, ED, Cavanaugh, K, Lewis, JB, Ikizler, TA, , . CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol, 5(1), 24-33, 2010. PMCID:2801650

Lewis, JB. Blood pressure control in chronic kidney disease: is less really more. J Am Soc Nephrol, 21(7), 1086-92, 2010.

McCoy, AB, Waitman, LR, Gadd, CS, Danciu, I, Smith, JP, Lewis, JB, Schildcrout, JS, Peterson, JF. A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report. Am J Kidney Dis, 56(5), 832-41, 2010.

Persson, F, Lewis, JB, Lewis, EJ, Rossing, P, Hollenberg, NK, Parving, HH, , . Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy. Diabetes Care, 33(11), 2304-9, 2010. PMCID:2944247

Siew, ED, Matheny, ME, Ikizler, TA, Lewis, JB, Miller, RA, Waitman, LR, Go, AS, Parikh, CR, Peterson, JF. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int, 77(6), 536-42, 2010. PMCID:2929703

Sipsma, HL, Ickovics, JR, Lewis, JB, Ethier, KA, Kershaw, TS. Adolescent pregnancy desire and pregnancy incidence. Womens Health Issues, 21(2), 110-6, 2010.

Toto, RD, Greene, T, Hebert, LA, Hiremath, L, Lea, JP, Lewis, JB, Pogue, V, Sika, M, Wang, X, , . Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis, 56(5), 896-906, 2010.

Dwyer, JP, Greco, BA, Lewis, JB. Evaluation of renal artery stenosis in dialysis patients. Semin Dial, 22(5), 519-23, 2009. PMCID:2801650

Bhave, G, Lewis, JB, Chang, SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol, 180(3), 830-5; discussion 835, 2008. PMCID:2801650

Basi, S, Lewis, JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes in diabetic patients. Curr Diab Rep, 7(6), 439-42, 2007. PMCID:2801650

Basi, S, Lewis, JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis, 47(6), 927-46, 2006. PMCID:2801650

Fischbach, BV, Trout, KL, Lewis, J, Luis, CA, Sika, M. WAGR syndrome: a clinical review of 54 cases. Pediatrics, 116(4), 984-8, 2005.

Lewis, J, Greene, T, Appel, L, Contreras, G, Douglas, J, Lash, J, Toto, R, Van Lente, F, Wang, X, Wright, JT, , . A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol, 15(12), 3175-83, 2004.

Merrell, K, Southwick, K, Graves, SW, Esplin, MS, Lewis, NE, Thulin, CD. Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry. J Biomol Tech, 15(4), 238-48, 2004. PMCID:2291707

Smith, JP, Lewis, JB. Hypertension management: special considerations in chronic kidney disease patients. Curr Hypertens Rep, 6(6), 462-8, 2004.

Gassman JJ, Greene T, Wright JT, Agodoa L, Bakris G, Beck GJ, Douglas J, Jamerson K, Lewis J, Kutner M, Randall OS and Wang SR for the AASK Group. Design and Statistical Aspects of the African American Study of Kidney Disease and Hypertension (AASK). JASN 14:, 2003. JASN, 14, , 2003.

Nigbor, DA, Lewis, JB. Use of calcium antagonists in renal patients: therapeutic benefit or medical malpractice. Curr Hypertens Rep, 5(5), 430-6, 2003.

Agodoa L, Appel L, Charleston J, Bakris, G, Cheek D, Douglas-Baltimore J, Gassman J, Glassock R, Greene T, Hebert L, Jamerson K, Lewis J, Phillips R, Toto R, Wright J. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK Trial. Journal of the American Medical Association., 288, 2421-31, 2002.

Allen KL, Miskulin D, Guofen Y, Dwyer JT, Frydrych A, Leung J, Poole D and the Hemodialysis (HEMO) Study Group. Association of nutritional markers with physical and mental health in prevalent hemodialysis patients from the HEMO Study. . Journal of Renal Nutrition., 3(12), 160-169, 2002.

Beddhu S, Kaysen GA, Yan G, Sarnak M, Agodoa L, Ornt D, Cheung AK for the HEMO Study Group. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. . American Journal of Kidney Disease, 4(40), 721-727, 2002.

Burrowes JD, Cockram DB, Dwyer JT, Larive B, Paranandi L, Bergen C, Poole D and the HEMO Study Group. Cross-sectional relationship between dietary protein and energy intake, nutritional status, functional status and comorbidity in older vs. younger hemodialysis patients. Journal of Renal Nutrition. , 2(12), 87-95, 2002.

Cheung AK, Yan G, Greene T, Daugirdas JT, Dwyer JT, Levin NW, Ornt DB, Schulman G, Eknoyan G and the HEMO Study Group. Seasonal Variations in Clinical and Laboratory Variables among Chronic Hemodialysis Patients. . . Journal of the American Society of Nephrology, 13, 2345-2352, 2002.

Kusek J, Greene P, Wang S-R, Beck G, West D, Jamerson K, Agodoa L, Faulkner M, Level B, and the AASK Study Group. Cross-sectional study of health-related quality of life in African Americans with chronic renal insufficiency: The African American Study of Kidney Disease and Hypertension (AASK) Trial. . American Journal of Kidney Diseases., 39, 513-24, 2002.

Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JB, Lewis JL, Rocco MV, and the HEMO Study Group. Relationship between volume status and blood pressure during chronic hemodialysis. . Kidney International , 61,1, 266-275, 2002.

Rocco MV, Paranandi L, Burrowes JD, Cockram DB, Dwyer JT, Kusek JW, Leung J, Makoff R, Maroni B, Poole D and the HEMO Study Group. Nutritional Status in the HEMO Study cohort at baseline. 39(2):245-256, 2002. American Journal of Kidney Disease. , 2(39), 245-256, 2002.

Rocco MV, Yan G, Gassman JJ, Lewis JB, Ornt D, Weiss B, Levey AS and the HEMO Study Group. Comparison of causes of death using HEMO Study and HCFA ESRD death notification classification systems. American Journal of Kidney Disease., 1(39), 146-153, 2002.

Wright JT, Agodoa L, Contreras G, Greene T, Douglas JG, Lash J, Randall O, Rogers N, Smith MC, Massry S and the AASK Study Group. Achieved blood pressure control in the African American Study of Kidney Disease and Hypertension (AASK). , 162(Archives of Internal Medicine.), 1636-43, 2002.

Agodoa LY, Appel L, Bakris GL et al. Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis. A Randomized Controlled Trial. JAMA Express , 285, June 6, 2001, 2001.

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I for the Collaborative Study Group. Renoprotective Effect of the Angiotensin Receptor Antagonist Irbesartan in Type 2 Diabetic Nephropathy". N Engl J Med , 345, 851-860, 2001.

Lewis J and Lewis EJ. In Memory of a Legendary Athlete: Measured Success in Diabetic Nephropathy. Semin Nephrol , 21, 124-132, 2001.

Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J Jr. for the AASK Study Group. Comparison of Crossectional Renal Function Measurements in African-Americans with Hypertensive Nephrosclerosis and of Primary Formulas to Estimate GFR. American Journal of Kidney Diseases, 38(4), 744-53, 2001.

Lewis, J, Agodoa, L, Cheek, D, Greene, T, Middleton, J, O''Connor, D, Ojo, A, Phillips, R, Sika, M, Wright, J, , . Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis, 38(4), 744-53, 2001.

Lewis, J, Lewis, EJ. In memory of a legendary athlete: measured success in diabetic nephropathy. Semin Nephrol, 21(2), 124-32, 2001.

Lewis, J, Salem, MM, Chertow, GM, Weisberg, LS, McGrew, F, Marbury, TC, Allgren, RL. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis, 36(4), 767-74, 2000.

Broumand, V, Paueksakon, P, Lewis, JB, Nadeau, J, Fogo, A. A 19-year-old man with hypertension, proteinuria, and renal insufficiency. Am J Kidney Dis, 34(4), 768-74, 1999.

Levey AS, Bosch JP, Breyer-Lewis J, Greene T, Rogers N, Roth D and the MDRD Study Group. A more accurate methods to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Annals of Internal Medicine , 130, 461-470, 1999.

Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ and the Collaborative Study Group. Effect of intensive blood pressure control on the course of Type I diabetic Nephropathy. Am J Kidney Dis , 34, 1-10, 1999.

Lewis, JB. Diabetic nephropathy in patients with type II diabetes. Geriatr Nephrol Urol, 9(3), 167-75, 1999.

Lewis, JB, Berl, T, Bain, RP, Rohde, RD, Lewis, EJ. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis, 34(5), 809-17, 1999.

Coggins CH, Breyer JA, Caggiula AW, Castaldo LS, Klahr S, Wang SR. Differences between women and men with chronic renal disease. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial] Nephrology, Dialysis, Transplantation, 13(6), 1430-7, 1998.

Lewis, JB. Microalbuminuria: accuracy or economics. Am J Kidney Dis, 32(3), 524-8, 1998.

Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis JB, Battle D and the Collaborative Study Group. Renal Pathology in Type II Diabetes Mellitus: Relationship with retinopathy. Nephrol Dial Transplant, 13(10), 2547-2552, 1998.

*Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayettes RA, Sweet RM, Genter FC, Kurnik BRC, Conger JD, Sayegh MH for the Auriculin Anaritide Acute Renal Failure Study Group. Anaritide in Acute Tubular Necrosis. NEJM, 336, 828-834, 1997.

Coomer RW, Schulman G, Breyer JA, Shyr Y. Ambulatory Blood Pressure Monitoring in Dialysis Patients and Estimation of Mean Inter-Dialytic Blood Pressure. Am J Kidney Dis , 29(5), 678-84, 1997.

Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R and the AASK Pilot Study Investigators. Accuracy of the Diagnosis of Hypertensive Nephrosclerosis in African Americans: A Report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int, 51, 244-252, 1997.

Hebert LA, Kusek JW, Greene T, Agodoa LY, Jones CA, Breyer JA, Faubert P, Rolin HA, Wang SR. Differences Between Blacks and Whites in the Effect of Blood Pressure Control on the Progression of Renal Disease in the Modification of Diet in Renal Disease Study. Hypertension, 30(Pt1), 428-35, 1997.

Breyer JA, Bain R., Evans, JK, Nahman NS, et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int , 50, 1651-1658 , 1996.

Eknoyan G, Breyer JA, Nissenson A, Beck G, Schulman G, Kusek J. Response to: Wasserstein AG, The Mortality and Morbidity in Hemodialysis Study: Ethical issues. Seminars in Dialysis , 7, 369-372, 1995.

Klahr S, Breyer JA, Beck G, Dennis V, Hartman J, Roth D, Yamamoto M and MDRD Study Group. Dietary Protein Restriction, Blood Pressure Control of Renal Function in the Progress of Polycystic Kidney Disease. JASN, 5, 2037-2047, 1995.

Breyer JA, Hunsicker LG, Bain R., Lewis EJ and The Collaborative Study Group. Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Kidney Int , 45(45), S156-S160, 1994.

Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM. Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int, 46, 1178-1183, 1994.

Breyer JA, Harbison MA. Isolation of Human Immunodeficiency Virus from Peritoneal Dialysate. Am J Kidney Dis , 21(1), 23-25, 1993.

Lewis EJ, Hunsicker LG, Bain R., Rohde RD for the Collaborative Study Group. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy. N Engl J Med , 329, 1456-1462, 1993.

Breyer JA. Diabetic Nephropathy in Insulin-Dependent Patients. Am J Kidney Dis , 20(6), 533-547, 1992.


Postdoctoral Position Available
N/A

Postdoctoral Position Details
N/A

Updated Date
05/07/2007



Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.